CancerX and our provider champions are so glad to have Encapsulate in the 2025 Accelerator!
CancerX shared a post on LinkedIn:
“CancerX and our provider champions are so glad to have Encapsulate in the 2025 Accelerator!
They’re trying to solve one of oncology’s most pressing challenges: ensuring patients receive treatments that will actually work for them, rather than costly and time-consuming therapies that may prove ineffective.
Encapsulate’s novel technology screens microtumors derived from patient biopsies against existing clinical treatment regimens, generating personalized insights to guide treatment decisions in just days.
This revolutionary approach to precision oncology helps clinicians select the most effective therapy for each unique patient, potentially avoiding unsuccessful treatment cycles, reducing side effects, and improving outcomes.
We are all looking forward to supporting their journey as they work to ensure every cancer patient receives the right treatment from the start!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023